Data as of Dec 24
| -0.05 / -3.45%|
The 2 analysts offering 12-month price forecasts for Alexza Pharmaceuticals Inc have a median target of 6.25, with a high estimate of 10.00 and a low estimate of 2.50. The median estimate represents a +346.43% increase from the last price of 1.40.
The current consensus among 2 polled investment analysts is to Buy stock in Alexza Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.